𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Gene Therapy in Inflammatory Diseases

✍ Scribed by Christopher H. Evans, Paul D. Robbins (auth.), Prof. Christopher H. Evans, Prof. Paul D. Robbins (eds.)


Publisher
BirkhΓ€user Basel
Year
2000
Tongue
English
Leaves
263
Series
Progress in Inflammation Research
Edition
1
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


Gene therapy for inflammatory diseases is a new , burgeoning field of medicine. Edited by the undisputed pioneers of this area of research, this volume is the first devoted to its topic. It contains thirteen chapters, each written by leaders in their respective fields, that summarize the state of the art in developing novel, gene based treatments for inflammatory diseases. As well as providing an introduction to the basic concepts of gene therapy and the use of naked DNA approaches, the book describes the advances that have been made in applying them to arthritis, lupus, multiple sclerosis, diabetes, Sjogren`s syndrome and transplantation.One chapter is devoted to discussing the first human clinical trials that apply gene therapy to the treatment of an inflammatory disease. As well as providing novel therapeutic approaches, gene therapy facilitates the development of new and improved animal models of disease; a chapter describing these advances is also included. As an up-to-date, timely book written by th

✦ Table of Contents


Front Matter....Pages i-xii
Gene therapy for inflammatory diseases β€” basic concepts....Pages 1-11
Gene therapy for rheumatoid arthritis: preclinical studies....Pages 13-34
Cartilage erosion in rheumatoid arthritis: studies in SCID mouse model....Pages 35-51
Gene therapy for rheumatoid arthritis: clinical studies....Pages 53-63
Cytokine gene therapy of allergic airways inflammation....Pages 65-81
Gene therapy for inflammatory diseases of the salivary glands....Pages 83-93
Gene therapy for management of lupus: Correction of Fas and Fas ligand-induced apoptosis in murine disease β€” therapeutic rationale and strategies....Pages 95-117
Gene therapy for multiple sclerosis....Pages 119-131
Gene therapy for type I diabetes mellitus....Pages 133-162
Gene transfer to facilitate transplantation....Pages 163-204
DNA vaccination as an anti-inflammatory strategy....Pages 205-229
Naked DNA as a gene delivery vehicle in inflammatory diseases....Pages 231-239
Animal models of arthritis generated by gene transfer....Pages 241-255
Back Matter....Pages 256-260

✦ Subjects


Surgical Orthopedics; Human Genetics; Molecular Medicine; Rheumatology


πŸ“œ SIMILAR VOLUMES


Gene Therapy for Autoimmune and Inflamma
✍ Yuti Chernajovsky, Paul D. Robbins πŸ“‚ Library πŸ“… 2010 πŸ› Springer Basel 🌐 English

This book addresses the latest advances in viral and non-viral vectors, novel targets and methods for the treatment of autoimmune and inflammatory disease with a main focus in pre-clinical testing with up to date clinical trials. The first section of the book deals with current research approaches f

Gene Therapy for Autoimmune and Inflamma
✍ Florence Apparailly, Paul Peter Tak (auth.), Yuti Chernajovsky, Paul D. Robbins πŸ“‚ Library πŸ“… 2010 πŸ› Springer Basel 🌐 English

<p>In this monograph about gene therapy of autoimmune and inflammatory d- orders we have gathered international experts and leaders from different fields to review the state of the art advances on topics ranging from disease entities to vectors and engineered cells. The different approaches describe

Behcet's Disease (Inflammatory Disease a
✍ Desmond Oduffy πŸ“‚ Library πŸ“… 1991 πŸ› Informa Healthcare 🌐 English

Ninety-three papers presented at the Fifth International Conference on Behcets' Disease held at the Mayo Clinic in Rochester, Minnesota, September 1989, are organized within four sections: diagnostic criteria and epidemiology; clinical manifestations ocular,, neurological, vascular and pulmonary, cu

Next-Generation Therapies and Technologi
✍ Paola Mina-Osorio (eds.) πŸ“‚ Library πŸ“… 2017 πŸ› Springer International Publishing 🌐 English

<p><p>As our understanding of immune mediated chronic inflammatory diseases (IMIDs) grows, it becomes more and more clear that these conditions result from the convergence of a multitude of pathogenic mechanisms whose relative individual contribution is different in different patient subsets.</p><p>